INSIGHTS ON CLINICAL TRIAL DESIGN
-
Analyzing The FDA's Approach To Diversity In Clinical Trials
Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
-
Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design
Explore how modern clinical trial design is being transformed by a rich array of data sources through this clear roadmap for navigating the evolving complexities of the industry.
-
Why Ophthalmology Assessments Are Non-Negotiable
Learn about the challenges researchers face when incorporating ophthalmology assessments into clinical trials, and how you can address those obstacles to the benefit of your trial and its participants.
-
What Does 2025 Hold For Pharma?
Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.
-
Virtual Clinical Trials For Ophthalmic Measures12/4/2025
Remote ophthalmic assessments such as BCVA, OCT, and IOP expand trial access and efficiency, preserving data quality while reducing site burden and boosting patient engagement.
-
Mergers And Acquisitions: How Institutional Knowledge Protecting Value5/27/2026
M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.
-
Precision Feasibility And RWD Can Boost Participant Recruitment11/17/2025
Discover how integrating independent, holistic data with precision feasibility strategies can transform site enablement and patient recruitment to unlock new levels of trial success.
-
Your CRAs Aren't Monitoring. They're Managing Workarounds.5/11/2026
CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.
-
Defining And Implementing The Right Oncology Digital Strategy11/7/2024
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.
-
Our dermatology studies provide results that are more than skin deep. Because the skin is the largest and most easily accessible organ, our dermatology research also facilitates drug development in other areas, including immunology and endocrinology. In addition, we are engaged in studying ways to improve wound healing.
-
Automate protocol design, database builds, and validation to cut study setup from months to days — enabling faster analytics, earlier insights, and trial simulation.
-
Validate endpoint performance and security before deployment with structured UAT that reduces risk, ensures compliance, and enhances user experience through real-world testing.
-
Traditional clinical trial models can create financial burden by neglecting participant needs – but effective use of stipends can allow participants to fully engage without financial worries.